Business
Nobel Closes Final Tranche of LIFE Offering
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUT...
About this update from Nobel Resources Corp
[{"type":"text","content":"Nobel Closes Final Tranche of LIFE Offering\nTHIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Nobel Resources Corp. (TSX–V: NBLC; OTCQB: NBTRF) (the “Company” or “Nobel”) announces it has closed the second and final tranche of its previously announced private placement of units (the “LIFE Offering”) pursuant to which the Company has issued 4,250,000 units (the “Units”) at a price of $0.05 per Unit for aggregate gross proceeds of $212,500 (the “LIFE Second Tranche”). The LIFE Offering has closed on a fully-subscribed basis and, in aggregate, the Company has issued thereunder 50,000,000 Units for gross proceeds of $2,500,000. Each Unit consists of one common share of the Company (each, a “Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder to purchase one Share at a price of $0.06 for a period of 24 months from the date hereof. The Warrants will not be exercisable until 70 days after today’s date. The LIFE Offering was led by iA Private Wealth Inc. (“iA”) whereby iA acted as lead agent and bookrunner on behalf of a syndicate of agents comprised of Velocity Trade Capital Ltd. and Haywood Securities Inc.   In connection with the LIFE Offering, the Agents received an aggregate cash fee equal to $14,875. In addition, the Company issued to the Agents 297,500 non-transferable broker warrants (the “Broker Warrants”). Each Broker Warrant is exercisable to acquire one Share at an exercise price equal to $0.05 for a period of 24 months from today’s date. The Shares and Warrants issued pursuant to the LIFE Second Tranche are not subject to a statutory hold period pursuant to applicable Canadian securities laws as the LIFE Second Tranche was completed pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The LIFE Second Tranche remains subject t...